Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0151744 (
myocardial ischemia
)
31,282
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
According to recent statistics for the time span 1951-1970, the mortality ratio of diabetics to non-diabetics was 335% (46). For those diabetics who were younger than 15 years when entering the study, the mortality ratio was 1127%, with a mean life expectancy of another 32 years, as compared to 59 years for non-diabetics. Among the major causes of disablement and early death are
ischemic heart disease
, retinopathy, nephropathy, peripheral vascular disease and neuropathy. In spite of newer, more potent and highly purified insulins, development of human insulin, change of once-daily injection to twice-daily insulin therapy (47), and the introduction of portable insulin infusion pumps, diabetes is still a high-risk disease, far from being controlled. Considering that the present mode of insulin administration is by the subcutaneous route by which the insulin is presented to the body in a nonphysiological manner, because the insulin is peripherally administered to the systemic circulation instead of portally, new therapeutic ways for insulin administration are worth study. During the past years, considerable interest has arisen in the rectal route of administration. Based on a physiological-kinetic model presented in this paper, utilization of the first-pass effect inherent to the rectal anatomy offers a physiological insulin input via the rectal route of administration. A review on the present state of rectal insulin administration is given, and experimental data from our laboratories are presented. The usefulness of sorption promoters on rectal insulin absorption is discussed. The "effectiveness" of rectal insulin preparations is suggested to be evaluated by four criteria: the pharmacological availability via the area under the % glucose reduction-time profile, the maximum glucose concentration reduction, Cmax, the time to reach the maximum reduction, tmax, and the mean residence time for glucose reduction,
MRT
.
...
PMID:Rectal administration of insulin. 639 94
The study aimed to compare the pharmacokinetic properties of quercitrin, astragalin, afzelin and taxifolin, four major bioactive components of
Polygonum orientale
inflorescence extracts, between sham-operated and
myocardial ischemia
-reperfusion injury (MIRI) rats.Rats were divided into two groups: MIRI model and sham-operated. The blood samples were collected according to the time schedule. The levels of quercitrin, astragalin, afzelin and taxifolin in the plasma at designated time points were determined using an HPLC-MS/MS method. Various pharmacokinetic parameters were estimated from the plasma concentration versus time data using non-compartmental methods. After the administration of the Chinese herb
Polygonum orientale
inflorescence extracts, the
C
max
, AUC, as well as
MRT
, increased, while CL decreased, in MIRI model compared to the sham-operated animals.These results suggest that the pathological damage of ischemia-reperfusion had a significant impact on the pharmacological effects of
Polygonum orientale
inflorescence extracts on
ischemic heart disease
.The method had been successfully applied to evaluate the pharmacokinetics of quercitrin, astragalin, afzelin and taxifolin in rat plasma after the oral administration of Chinese herb
Polygonum orientale
inflorescence extracts in rats.
...
PMID:Comparative pharmacokinetics of quercitrin, astragalin, afzelin and taxifolin in plasma after oral administration of
Polygonum orientale
inflorescence in sham-operated and myocardial ischemia-reperfusion injury rats. 3179 Nov 86